Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07354074 |
| Title | Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | child | adult |
| Covered Countries | CAN | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Novartis Investigative Site | RECRUITING | Brisbane | Queensland | 4101 | Australia | Details |
| Novartis Investigative Site | RECRUITING | Montreal | Quebec | H3T 1C5 | Canada | Details |
| Novartis Investigative Site | RECRUITING | Seoul | 03080 | South Korea | Details | |
| Novartis Investigative Site | RECRUITING | Seoul | 06591 | South Korea | Details |